NDC 0591-2136-55 - Propofol
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0591-2136
- Requested NDC
- 0591-2136-55
- Package NDCs from labels
- 0591-2136-55, 0591-2136-51, 0591-2136-57, 0591-2136-68, 0591-2136-80, 0591-2136-95
- Manufacturer
- Actavis Pharma, Inc.
- Effective date
- 2023-05-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Propofol - Actavis Pharma, Inc. | Actavis Pharma, Inc. | 2023-05-30 | HUMAN PRESCRIPTION DRUG LABEL |
| PROPOFOL - Henry Schein, Inc. | Henry Schein, Inc. | 2022-01-13 | HUMAN PRESCRIPTION DRUG LABEL |
| PROPOFOL - General Injectables & Vaccines, Inc. | General Injectables & Vaccines, Inc. | 2021-12-22 | HUMAN PRESCRIPTION DRUG LABEL |
| Propofol - A-S Medication Solutions | A-S Medication Solutions | 2021-04-15 | HUMAN PRESCRIPTION DRUG LABEL |
| Propofol | General Injectables and Vaccines, Inc. | 2018-04-19 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0591-2136-51 | ML - Milliliter | 0591-2136 | 0b14f2f2-28a4-4fb5-a669-08abd4efc03a | 1 | 2016-02-04 |
| 0591-2136-55 | ML - Milliliter | 0591-2136 | c7340b05-171e-42b9-9aaa-f4423b6cba5b | 1 | 2016-02-04 |
| 0591-2136-57 | ML - Milliliter | 0591-2136 | 20f74f85-7313-40e5-a1bd-99d35d50d3cd | 1 | 2016-02-04 |
| 0591-2136-68 | ML - Milliliter | 0591-2136 | 47d8a6dd-b9a7-457a-a1e8-e8e835d9157a | 1 | 2016-02-04 |
| 0591-2136-80 | ML - Milliliter | 0591-2136 | ecc8f542-06b4-4ab8-8638-70de2da9f8bd | 1 | 2016-02-04 |
| 0591-2136-95 | ML - Milliliter | 0591-2136 | 0d8814c1-098b-4f9e-8b00-4e25f3db5dc8 | 1 | 2016-02-04 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SUKKHI Polyamino Sugar Condensate Massage Cream | SUKKHI POLYAMINO SUGAR CONDENSATE MASSAGE CREAM | GUANGZHOU YUSONG FINE CHEMICLS Co., Ltd | 34aaf4ef-26dc-f87e-e063-6394a90a9a59 | 2025-05-08 | Warnings | PDC6A3C0OX |
| Propofol | PROPOFOL | Avenacy, LLC | de351d5f-581d-4768-a4af-fbd8e5bce264 | 2025-04-30 | Warnings, Adverse reactions | YI7VU623SF |
| ThroatSpray | ECHINACEA (ANGUSTIFOLIA), EUGENIA CARYOPHYLLATA, GLYCERINUM, MYRRHA, SALVIA OFFICINALIS, SPILANTHES OLERACEA, THYMUS SERPYLLUM, BAPTISIA TINCTORIA, PHYTOLACCA DECANDRA, HYDRASTIS CANADENSIS, APIS MELLIFICA, BELLADONNA, LACHESIS MUTUS, MERCURIUS SOLUBILIS, HEPAR SULPHURIS CALCAREUM | Energique, Inc. | 125ffbf4-681e-451c-a96d-0b6416619474 | 2025-04-29 | Warnings | PDC6A3C0OX |
| Diprivan | PROPOFOL | Fresenius Kabi USA, LLC | d1ae9e26-ffd6-43df-bbd6-869cdede6afe | 2025-04-21 | Warnings, Adverse reactions | YI7VU623SF |
| SODIUM PHENYLACETATE and SODIUM BENZOATE | SODIUM PHENYLACETATE AND SODIUM BENZOATE | Ailex Pharmaceuticals, LLC | 329655ae-c3c0-46b2-a925-e49777f2076b | 2025-03-30 | Warnings, Adverse reactions | OJ245FE5EU |
| Addiclenz | ASPARTAME, BENZALKONIUM CHLORIDE, FORMALINUM, METHYLENE CHLORIDE, METHYLPARABEN, PROPYLPARABEN, SODIUM BENZOATE, SODIUM CITRATE, TITANIUM DIOXIDE, ZINCUM OXYDATUM, ARSENICUM ALBUM, BETA VULGARIS, BISPHENOL A, BOLDO, CHELIDONIUM MAJUS, COBALTUM METALLICUM, CUPRUM METALLICUM, GLYPHOSATE, IODIUM, LYCOPODIUM CLAVATUM, PETROSELINUM SATIVUM, PHOSPHORICUM ACIDUM, SELENIUM METALLICUM, TARAXACUM OFFICINALE, ZINCUM METALLICUM | Deseret Biologicals, Inc. | 25036c26-1c21-4e5a-b4db-b8e177458341 | 2025-03-11 | Warnings | OJ245FE5EU |
| Curist Hemorrhoid Fissure Relief | LIDOCAINE | Little Pharma, Inc | 2fb02b00-acdb-5184-e063-6294a90ae1c8 | 2025-03-06 | Warnings | PDC6A3C0OX |
| Thera Plus Hemorrhoidal | GLYCERIN, PETROLATUM, PHENYLEPHRINE HYDROCHLORIDE, PRAMOXINE HYDROCHLORIDE | FOURSTAR GROUP USA, INC. | 87143a7a-7b2d-4b67-afda-2355697e7300 | 2025-03-04 | Warnings | PDC6A3C0OX |
| Clear Eyes Maximum Redness Relief | NAPHAZOLINE HYDROCHLORIDE AND GLYCERIN | Prestige Brands Holdings, Inc. | c3b0e344-68dd-4c35-bf46-744e612a5b15 | 2025-02-28 | Warnings | PDC6A3C0OX |
| Blink Nourish Dry Eye | GLYCERIN | Bausch & Lomb Incorporated | cf2b4e19-af0a-472e-9a2d-9b4fa3e9c9a4 | 2025-02-25 | Warnings | PDC6A3C0OX |
| Diprivan | PROPOFOL | Fresenius Kabi USA, LLC | ee0c3437-614d-4631-a061-257f5f60c70b | 2025-02-20 | Warnings, Adverse reactions | YI7VU623SF |
| Bestmade Natural Products BM164 | ACID PHOS, ARUM TRYPH, BALSAMUM PERU, CAUSTICUM, EQUISETUM, GLYCERINUM, HELONIAS DIO | Bestmade Natural Products | 2e6e49aa-278e-5499-e063-6394a90a999c | 2025-02-18 | Warnings | PDC6A3C0OX |
| SODIUM PHENYLACETATE and SODIUM BENZOATE | SODIUM PHENYLACETATE AND SODIUM BENZOATE | Omnivium Pharmaceuticals LLC | 9067c301-74f9-457a-9b0f-b7e9b06a3508 | 2025-02-15 | Warnings, Adverse reactions | OJ245FE5EU |
| Hydropure Lubricating Eye Drops | GLYCERIN | OTE North America | 17f5b6e5-dc14-45c7-e063-6294a90af43d | 2025-02-14 | Warnings | PDC6A3C0OX |
| Tyson 2.0 Mike Red Eye Drops For Dry High Eyes | GLYCERIN, NAPHAZOLINE HCL | Jbrands Pharma L.L.C. | 288e9c85-0562-89bf-e063-6394a90a110d | 2025-02-07 | Warnings | PDC6A3C0OX |
| AN12 Secret Therapy Feminine Cleanser | GLYCERIN | BESTVALUE Co., Ltd | d2117c4c-9f1a-3a6e-e053-2995a90a0cc8 | 2025-01-31 | Warnings | PDC6A3C0OX |
| AN12 Skin Therapy Vita-B Aloe Soothing Gel | GLYCERIN | BESTVALUE Co., Ltd | d274c973-057d-1c9f-e053-2995a90a82b1 | 2025-01-31 | Warnings | PDC6A3C0OX |
| AN12 ANUS PREMIUM CLEANSER | GLYCERIN, ALLANTOIN | BESTVALUE Co., Ltd | d11b7443-2dfc-3e17-e053-2a95a90afb76 | 2025-01-31 | Warnings | PDC6A3C0OX |
| OASIS Tears Lubricant Eye | GLYCERIN | OASIS Medical, Inc. | 00071697-4ac6-4962-8eee-388b8b52bd40 | 2025-01-22 | Warnings | PDC6A3C0OX |
| OASIS Tears Plus Preservative-Free Lubricant Eye | GLYCERIN | OASIS Medical, Inc. | ea931c0f-c61e-4771-84f1-0274b1c3e28e | 2025-01-22 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.